• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Quick Take: Association of Blood and Cerebrospinal Fluid Tau Level and Other Biomarkers With Survival Time in Sporadic Creutzfeldt-Jakob Disease

byConstance WuandAliya Ramjaun
May 19, 2019
in Chronic Disease, Imaging and Intervention, Neurology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

RELATED REPORTS

Plasma p-tau217 is an accurate plasma biomarker of pathologic cerebral changes in patients with Down Syndrome

#VisualAbstract: Anti-tau antibody Semorinemab not shown to slow clinical progression of Alzheimer’s disease

Biomarkers demonstrate neuroprognostic accuracy for patients with hypoxic ischemic brain injury following cardiac arrest

Human prion disease, also known as Creutzfeldt-Jakob disease (CJD), is a neurodegenerative disease caused by abnormally folded prion proteins. The progression of CJD is rapid, with time from diagnosis to death being approximately 4 to 6 months. Currently, there is a need to more accurately predict disease duration in order to improve clinical management and stratify patients for clinical trials. Fluid biomarkers have been studied as a way to predict disease course in sporadic CJD (sCJD). In this cohort study, investigators performed neurological tests and collected cerebral spinal fluid (CSF) and blood from 188 participants with sCJD in order to examine the association between fluid biomarkers and disease progression. Investigators found that greater baseline levels of total tau (t-tau) were associated with shorter survival; this was true for both plasma (HR 5.8, 5% CI 2.3 to 14.8, p<0.001) and CSF (HR 1.6, 95% CI 1.2 to 2.1, p<0.001). Plasma and CSF t-tau levels were correlated (r=0.74, 95% CI 0.50 to 0.90 p<0.001). Plasma neurofilament light (NfL) levels, CSF nFL levels, total tau: phosphorylated tau ratios, and neuro-specific enolase levels were other fluid biomarkers associated with survival. Codon 129 genotypes of the PNRP gene and Barthel index were also associated with survival time. The results from this study suggest that using plasma and CSF t-tau levels could contribute important predictive information for patients with sCJD. It is important to note, however, that this study was limited with only a relatively small subsample of patients with all plasma and CSF biomarkers.

Click to read the study in JAMA Neurology

Image: PD

©2019 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc

Tags: biomarkerscerebral spinal fluid (CSF)Creutzfeldt-Jakob disease (CJD)priontau protein
Previous Post

#VisualAbstract: Effect of Trans-Nasal Evaporative Intra-arrest Cooling on Functional Neurologic Outcome in Out-of-Hospital Cardiac Arrest

Next Post

#VisualAbstract: A Randomized Trial of Progesterone in Women with Bleeding in Early Pregnancy

RelatedReports

Brain lesions on MRI linked with subsequent increased stroke risk
Chronic Disease

Plasma p-tau217 is an accurate plasma biomarker of pathologic cerebral changes in patients with Down Syndrome

July 7, 2022
#VisualAbstract: Varenicline improves successful smoking cessation amongst African American daily smokers: KIS-IV Trial
StudyGraphics

#VisualAbstract: Anti-tau antibody Semorinemab not shown to slow clinical progression of Alzheimer’s disease

June 29, 2022
Quick Take: Efficacy of prehospital criteria in identifying trauma patients susceptible to undertriage
Cardiology

Biomarkers demonstrate neuroprognostic accuracy for patients with hypoxic ischemic brain injury following cardiac arrest

April 7, 2022
“No Evidence of Disease Activity” may be useful goal in multiple sclerosis
Chronic Disease

Metagenomic next-generation sequencing of cerebrospinal fluid yielded improved sensitivity and specificity for the detection of central nervous system neoplasms

September 15, 2021
Next Post
#VisualAbstract: A Randomized Trial of Progesterone in Women with Bleeding in Early Pregnancy

#VisualAbstract: A Randomized Trial of Progesterone in Women with Bleeding in Early Pregnancy

Standardized developmental screening of refugee children is recommended

Duration, type of poverty affect children’s readiness for school

Primary seat belt laws associated with lower motor vehicle fatality

Young drivers with ADHD linked with higher rates of crashes and violations

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Abnormal menstruation may be associated with worse cardiometabolic outcomes later in life
  • Past infection with pre-omicron variants of COVID-19 protects against re-infection
  • No difference in complete expulsion of intrauterine device between early and standard interval postpartum placement
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options